International management consulting firm Insigniam announced that its consultant, Ira Katz, has been named to the editorial advisory board for Applied Clinical Trials.
Applied Clinical Trials is a global, peer-reviewed publication with coverage that features the process of managing clinical trials at the intersection where pharmaceutical product developers meet the strictly regulated medical researchers who test their new drugs. It delivers in-depth information to pharmaceutical, CRO, laboratory, regulatory, academic and clinical research professionals about the products, services and companies that are impacting the industry and their daily work.
Ira Katz has more than 30 years of experience in drug development at three major biopharmaceutical companies and brings rich and diverse experience in key aspects of drug research and development process to his work at Insigniam. His background includes clinical research, clinical operations, quality assurance, project management and project portfolio management. Katz has taught various courses related to the clinical development of drugs as an adjunct professor in the Temple University School of Pharmacy’s QA/RA Master’s program and Mercer County Community College’s Clinical Development and Regulatory Affairs program.
“We are so pleased to see Ira being recognized for his expertise in the pharmaceutical industry as a part of the Applied Clinical Trials editorial advisory board,” says Insigniam partner Jen Zimmer. “His work with our pharmaceutical clients has been very successful because he provides them the kind of insights that only someone with his depth and breadth of experience can contribute. I am sure Ira will be as great a contribution to Applied Clinical Trials.”
To learn more about Applied Clinical Trials, please visit them at http://www.appliedclinicaltrialsonline.com. To learn more about Insigniam and its consultants, visit them online at http://www.insigniam.com.
Insigniam has over 25 years experience working with large, complex organizations in generating breakthroughs in their management results — whether that be in topline growth, strategy implementation, better profitability, or culture change. Insigniam innovation consulting enables enterprises to identify new strategic frontiers, generate creativity and execute growth opportunities on those frontiers. By marrying breakthrough performance and innovation, Insigniam innovation consulting services are unparalleled in their potency to quickly create dramatic growth. Clients have documented, in aggregate, more than 50x ROI management results considered critical and essential to the success of their enterprises. Other Insigniam solutions include Enterprise Transformation, Breakthrough Projects, Transformational Leadership, and Managing Change. Offices are located in Philadelphia, Pa., Laguna Beach, Calif., Paris, and Hong Kong.